Research Square
Continuous Glucose Monitoring-Based Metrics with Fixed-Dose Combination Versus Co-administered Dapagliflozin/Metformin in Chinese Patients with Type 2 Diabetes Mellitus
Preprint: randomised trial in 305 peopleType 2 diabetes
Papers by Yinghong Kong
3 results
- Journal of Diabetes
Effectiveness and Safety of Fixed-Dose Combination Metformin and Empagliflozin in Type 2 Diabetes: A Prospective, Multicenter, Real-World Study From China
Cohort study of 2,602 peopleType 2 diabetes - ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of DAPA/MET Fixed-Dose Combination (FDC) vs. Co-Administration (Co-ADM) in Chinese Patients with T2DM
Trial in peopleInterventions